CDSCO Approval for Wegovy MASH Treatment
CDSCO Approval for Wegovy MASH Treatment General Studies Paper II: Health, Government Policies & Interventions Why in News? Recently, India’s Central Drugs Standard Control Organisation(CDSCO) approved Novo Nordisk’s Wegovy (semaglutide) for treating MASH. What is Metabolic Dysfunction-Associated Steatohepatitis (MASH)? Wegovy (Semaglutide): Mechanism, Uses and Approval Burden of Fatty Liver Disease in India Government Initiatives FAQs: […]
CDSCO Approval for Wegovy MASH Treatment Read More »









